Home > Insider Trading > Filing (0001209191-21-004925)

Filing Details

Accession Number:: 0001209191-21-004925
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-22 17:22:38
Reporting Period:: 2021-01-20

Accepted Time:: 2021-01-22 17:22:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1468748	Kodiak Sciences Inc.	KOD	Biological Products, (No Disgnostic Substances) (2836)	270476525

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754049	Jason Ehrlich	2631 Hanover Street Palo Alto CA 94304	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-01-20	26,950	$10.29	77,293	No	4	M	Direct
Common Stock	Disposition	2021-01-20	6,668	$159.96	70,625	No	4	S	Direct
Common Stock	Disposition	2021-01-20	4,204	$161.03	66,421	No	4	S	Direct
Common Stock	Disposition	2021-01-20	4,956	$162.05	61,465	No	4	S	Direct
Common Stock	Disposition	2021-01-20	2,061	$163.10	59,404	No	4	S	Direct
Common Stock	Disposition	2021-01-20	1,497	$164.51	57,907	No	4	S	Direct
Common Stock	Disposition	2021-01-20	3,132	$165.64	64,775	No	4	S	Direct
Common Stock	Disposition	2021-01-20	3,097	$166.51	51,678	No	4	S	Direct
Common Stock	Disposition	2021-01-20	1,335	$167.20	50,343	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-01-20	26,950	$0.00	26,950	$10.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
297,275		2028-08-29	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $159.51 to $160.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $160.56 to $161.51, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $161.70 to $162.65, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $162.75 to $163.68, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $164.03 to $164.91, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $165.11 to $166.04, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $166.12 to $167.00, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $167.14 to $167.68, inclusive.
Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.